Clinical Trial Update: NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is evaluating NBTXR3 with radiation therapy alone for locally advanced non-small cell lung cancer. The study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• NBTXR3 (hafnium oxide nanoparticles)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Locally-Advanced Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING